115 related articles for article (PubMed ID: 4024598)
1. [Experimental substantiation of using immunomodulators of the phenylimidazothiazole type for the correction of secondary immunologic insufficiency caused by poliomyelitis virus].
Giulling EV; Shirobokov VP; Korniushenko ON; Negrebetskaia EN; Rozenfel'd OL
Vrach Delo; 1985 Jun; (6):95-7. PubMed ID: 4024598
[No Abstract] [Full Text] [Related]
2. [The correction of a secondary immunological deficit caused by the Coxsackie B3 virus by using an immunomodulator of bacterial origin].
Semenova IB; Vasil'eva IG; Akatov AK
Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):83-4. PubMed ID: 8079587
[No Abstract] [Full Text] [Related]
3. [The use of immunomodulators to enhance postvaccinal immunity to experimental poliomyelitis].
Bondarenko VI; Zadorozhnaia VI; Buraia TA; Gritsenko LN
Mikrobiol Z; 1995; 57(6):41-5. PubMed ID: 8714398
[TBL] [Abstract][Full Text] [Related]
4. [Sodium nucleinate as a modulator of secondary immunological insufficiency and dysnucleotidosis in nonspecific inflammatory lung diseases].
Zemskov AM; Zemskov VM; Nikitin AV
Ter Arkh; 1993; 65(5):87-91. PubMed ID: 8036607
[No Abstract] [Full Text] [Related]
5. Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency.
Parvaneh N; Shahmahmoudi S; Tabatabai H; Zahraei M; Mousavi T; Esteghamati AR; Gooya MM; Mamishi S; Nategh R; Kew OM
J Clin Virol; 2007 Jun; 39(2):145-8. PubMed ID: 17509935
[TBL] [Abstract][Full Text] [Related]
6. [Combined immunocorrection--a prospective method for treating secondary immunodeficiency].
Perederiĭ VG; Zemskov AM; Provotorov VM; Nikitin AV; Evstratova EF
Vrach Delo; 1989 Jan; (1):96-8. PubMed ID: 2718463
[TBL] [Abstract][Full Text] [Related]
7. [Induction of immunologic deficiency by benzene and its correction by administration of anabol].
Karaulov AV; Ogarkov VI; Khromenkov IuI; Frash VN
Biull Eksp Biol Med; 1988 Apr; 105(4):457-9. PubMed ID: 3359030
[TBL] [Abstract][Full Text] [Related]
8. [Secondary immunodeficiency states and their correction with sodium nucleinate].
Zemskov AM; Perediriĭ VG; Zemskov VM; Provotorov VM; Nikitin AV
Ter Arkh; 1982; 54(4):55-8. PubMed ID: 7101158
[No Abstract] [Full Text] [Related]
9. [The immunocorrective action of the new synthetic hexapeptide imunofan in pharmacologically induced and ecological immunodeficiency].
Pisarev VM; Baĭmukanova GK; Tutel'ian AV; Pevnitskiĭ LA; Lebedev VV
Vestn Ross Akad Med Nauk; 1995; (12):22-7. PubMed ID: 8664598
[No Abstract] [Full Text] [Related]
10. [Secondary immunologic deficiency and its correction in cancer patients after radiation and combined therapy].
Filatov PP; Surinov BP
Med Radiol (Mosk); 1987 Sep; 32(9):73-7. PubMed ID: 3498873
[TBL] [Abstract][Full Text] [Related]
11. Medical negligence and vaccine associated paralytic poliomyelitis.
Paul Y
Indian Pediatr; 2001 Sep; 38(9):1068-9. PubMed ID: 11568394
[No Abstract] [Full Text] [Related]
12. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
13. Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease.
Lopez C; Biggar WD; Park BH; Good RA
J Pediatr; 1974 Apr; 84(4):497-502. PubMed ID: 4151810
[No Abstract] [Full Text] [Related]
14. [Changes of immune indices in pancreonecrosis and their correction].
Averkiev VL; Tarasenko VS; Latysheva TV; Proskuriakov VE; Averkieva LV
Khirurgiia (Mosk); 2003; (5):31-4. PubMed ID: 12792958
[TBL] [Abstract][Full Text] [Related]
15. Influence of the immunomodulators suramin, MER and clenbuterol on the haemopoiesis of mice with virus-induced Rauscher leukemia.
Zvetkova E; Chowdhury I; Rusev R; Janeva E; Nikolova E; Tzenov I; Trifonov S
Acta Microbiol Bulg; 1993; 29():47-53. PubMed ID: 8511998
[No Abstract] [Full Text] [Related]
16. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
[TBL] [Abstract][Full Text] [Related]
17. [The immunological effects of perftoran].
Pluzhnikov NN; Lobzin IuV; Kovelenov AIu; Zhelezkova EV; Gusev DA
Eksp Klin Farmakol; 1998; 61(5):34-6. PubMed ID: 9854631
[TBL] [Abstract][Full Text] [Related]
18. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
[TBL] [Abstract][Full Text] [Related]
19. [An evaluation of the immunotropic and hemopoietic effects of hyperbaric oxygenation as an experimental pathological model].
Pogabalo AV; Kazantseva NV; Sergeev AV; Uteshev BS
Eksp Klin Farmakol; 1997; 60(1):72-5. PubMed ID: 9162294
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic changes and their correction in different forms of acute cholecystitis in late middle-age and the aged].
Zatevakhin II; Krylov LB; Mamatkulov SM; Sabirov BU; Akhtamov DA
Khirurgiia (Mosk); 1985 Feb; (2):84-7. PubMed ID: 3981944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
